SynthesisBMC cancer2019

Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials.

Wei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.